Danaher closes in on a nearly $10bn deal for med tech company Masimo

{# Share Buttons Partial Variables: share_title — text to pre-fill in share dialogs share_url — canonical URL to share (use request.build_absolute_uri in parent) #}

Market Intelligence Analysis

AI-Powered
Why This Matters

Danaher is closing in on a nearly $10 billion deal to acquire Masimo, a medical technology company, despite being involved in a long-running intellectual property dispute with Apple.

Market Impact

Market impact analysis based on bullish sentiment with 80% confidence.

Sentiment
Bullish
AI Confidence
80%
Time Horizon
Short Term

Article Context

Note: This is a brief excerpt for context. Click below to read the full article on the original source.

Device maker is in a long-running intellectual property dispute with Apple

Continue Reading
Full article on Financial Times
Read Full Article
Original article published by Financial Times on February 17, 2026.
Analysis and insights provided by AnalystMarkets AI.